Feasibility and safety of vertebrobasilar artery cooling infusion (VACI) following thrombectomy for acute posterior circulation ischemic stroke: A pilot randomized controlled trial.

Furthermore, although the difference did not reach statistical significance, the VACI group exhibited a clinically notable reduction in mortality compared to the control group at both 90 days (10.0% vs. 20.0%; p = 0.658) and, more prominently, at 7 days (5.0% vs. 20.0%; p = 0.339) ( Fig. 5 ).

also in 111,027 other papers